Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BECTON DICKINSON & CO Director's Dealing 2023

Dec 12, 2023

30003_dirs_2023-12-12_3883c23a-87e0-47e5-8094-0c3be2a4f468.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2023-12-11

Reporting Person: Garrison Michael David (EVP & President Medical)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-11 Common Stock S 1239 $232.46 Disposed 7274 Direct